Studies that evaluated only patients with liver cirrhosis concluded that PIVKA‐II is a useful biomarker for diagnostic characterization of liver nodules and it provides higher diagnostic accuracy for HCC when combined with AFP.17, 18. Here, AFP is linked to hepatocellular carcinoma.